Loading clinical trials...
Loading clinical trials...
a Prospective, Single-arm, Symptom-based Score, to Evaluate the Tolerance of Extensive Hydrolyzed Whey Protein Milk Intervention Among Infant With Mild to Moderate CMPA
Conditions
Interventions
extensive hydrolyzed protein formula
Locations
5
Indonesia
Prof. Dr. dr. Zakiudin Munasir, Sp.A (K)'s private clinic
Tangerang, Banten, Indonesia
Siloam Hospital Lippo Vilage
Tangerang, Banten, Indonesia
dr. Martani Widjajanti Sukarlan, Sp.A (K)'s private clinic
Jakarta, DKI Jakarta, Indonesia
RSUPN Dr. Cipto Mangunkusumo Kencana and Kiara
Jakarta, DKI Jakarta, Indonesia
Hermina Hospital Depok
Depok, West Java, Indonesia
Start Date
July 14, 2023
Primary Completion Date
January 17, 2024
Completion Date
January 31, 2024
Last Updated
April 1, 2025
Lead Sponsor
Danone Specialized Nutrition Indonesia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions